Skip to content
Climedo logo — The leading European EDC for eCOA-focused post-approval tria...

Climedo

The leading European EDC for eCOA-focused post-approval trials and accelerated commercialization.

Founded 2017 Germany Germany 29 employees Seed Total: $6.18M Health Care, Pharmaceutical

General Information

Company Name Climedo
Founded Year 2017
Location Germany Germany
Employees 29
Industries Health Care, Pharmaceutical
Funding Stage Seed

BounceWatch is an independent company data service, not affiliated with Climedo. To contact Climedo, visit climedo.de.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Climedo compare?

A PDF of Climedo and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Climedo soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Climedo

Climedo is a Munich-based startup, founded in 2017, that offers an all-in-one eCOA and EDC solution with hybrid capabilities for non-interventional studies and real-world evidence. The company's patient-centric approach and real-time data insights empower clients in the Health Care and Pharmaceutical industries to better engage with healthcare professionals and key opinion leaders (KOLs). With over 1.7 million patients enrolled to date, Climedo has positioned itself as a trusted partner for pharma, medtech, CROs, and academia. In its last investment round on 16 February 2022, Climedo secured a €5.00M Seed Round investment from Nauta Capital, WestTech Ventures, and Prof. Dr. med. Christian Wallwiener. The company's slogan, "The leading European EDC for eCOA-focused post-approval trials and accelerated commercialization," underscores its focus on streamlining post-approval trials and accelerating the commercialization of medical innovations to reach more patients faster.

Business keywords: eCOA, EDC, Real-world evidence, Medical Research, Clinical Validation, Digital Healthcare, Pharma, BioTech, MedTech, Commercialization, Market Access, KOL engagement, Post-approval studies, Data reporting

Services & Products

eClinical platform
Real-World Evidence
Clinical Data Management

Target Customers

Pharmaceutical & Biotech companies MedTech companies Clinical Research Organizations Hospitals Research Institutes

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round €5.00M 3
Nauta Capital, WestTech Ventures +1
16 Feb 2022
Pre Seed Round €1.00M 1
WestTech Ventures
27 May 2019
Grant €50.00K 1
EIT Health
01 Nov 2017
Grant €130.00K -
01 Mar 2017

Climedo Alternatives & Competitors

View All Alternatives
Climedo vs
Cisiv
Cisiv United Kingdom

Global integrated digital platform for non-interventional research, registries and Expanded Access P...

Seed
17 employees
Health Care, Information Technology
Climedo vs
SHYFT Analytics
SHYFT Analytics United States

SHYFT Analytics is an industry leader in cloud data management and mobile analytics for the global l...

Series B
15 employees
Analytics, Health Care
Climedo vs
Verantos
Verantos United States

High-validity real-world evidence across all therapeutic areas at scale

Grant
57 employees
Health Care, Pharmaceutical

FAQ About Climedo

The leading European EDC for eCOA-focused post-approval trials and accelerated commercialization.
Climedo was founded in 2017.
Climedo is headquartered in Germany.
Climedo operates in Health Care and Pharmaceutical. Its work centres on eCOA, EDC, Real-world evidence and Medical Research. Its customers include Pharmaceutical & Biotech companies, MedTech companies and Clinical Research Organizations.
Climedo has approximately 29 employees.
Climedo has completed 4 funding rounds, raising a total of $6.18M. The latest funding stage is Seed.
Climedo offers: eClinical platform, Real-World Evidence, Clinical Data Management.
Top alternatives and competitors to Climedo include Cisiv, SHYFT Analytics, Verantos, Human Data Sciences, xCures. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Climedo and Cisiv are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Climedo, https://bouncewatch.com/company/climedo, updated 24 February 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout